Improved recovery of a fusion protein containing the antigenic domain 1 of the human cytomegalovirus glycoprotein B

Biotechnology Letters

Volumn 27, Issue 16, 2005, Pages 1241-1245

  Ferreira, S ^a   Sousa, F ^a   Queiroz, J A ^a   Domingues, F C ^a  

^a UNIVERSITY OF BEIRA INTERIOR   (Portugal)

Author keywords

Antigenic domain 1; Disruption method; Human cytomegalovirus; Inclusion bodies

Indexed keywords

ANTIGENS; DIAGNOSIS; ESCHERICHIA COLI; INCLUSIONS; SOLUBILITY;

ANTGENIC DOMAIN 1; DISRUPTION METHODS; HUMAN CYTOMEGALOVIRUS; INCLUSION BODIES;

PROTEINS;

GLYCOPROTEIN B, TYPE 1 HERPES SIMPLEX VIRUS; HYBRID PROTEIN; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN;

ARTICLE; CELL FRACTIONATION; CENTRIFUGATION; ESCHERICHIA COLI; GENETICS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; PROTEIN ENGINEERING; PROTEIN TERTIARY STRUCTURE; ULTRASOUND;

ANTIGENS, VIRAL; CELL FRACTIONATION; CENTRIFUGATION; ESCHERICHIA COLI; HUMANS; PROTEIN ENGINEERING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; SONICATION; VIRAL ENVELOPE PROTEINS;

ESCHERICHIA COLI; HUMAN HERPESVIRUS 5;

EID: 24744466678     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-005-0024-x     Document Type: Article

References (14)

1. W Britt M Mach 1996 Human cytomegalovirus glycoproteins Intervirology 39 401 412
2. M Eshaghi W Tan W Chin K Yusoff 2005 Purification of the extra-cellular domain of Nipah virus glycoprotein produced in Escherichia coli and possible application in diagnosis J. Biotechnol 116 221 226
3. B Kropff M Landini M Mach 1993 An ELISA using recombinant proteins for the detection of neutralizing antibodies against human cytomegalovirus J. Med. Virol 39 187 195
4. R Kuboi H Umakoshi N Takagi I Komasawa 1995 Optimal disruption methods for the selective recovery of β-galactosidase from Escherichia coli J. Ferment. Bioeng 79 335 341
5. A Middelberg 1995 Process-scale disruption of microorganisms Biotechnol. Adv 13 491 551
6. A Middelberg 2002 Preparative protein refolding Trends Biotechnol 20 437 443
7. S Misawa I Kumagai 1999 Refolding of therapeutic proteins produced in Escherichia coli as inclusion bodies Biopolymers 51 297 307
8. M Ohlin V Sundqvist M Mach B Wahren C Borrebaeck 1993 Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies J. Virol 67 703 710
9. Sambrook J, Russell D (1989) Molecular Cloning - A Laboratory Manual, 31:Cold Spring Harbor Laboratory Press.
10. A Speckner D Glykofrydes M Ohlin M Mach 1999 Antigenic domain 1 of the human cytomegalovirus glycoprotein B induces a multitude of different antibodies which, when combined, results in incomplete virus neutralization J. Gen. Virol 80 2183 2191
11. A Speckner B Kropff S Knor M Mach 2000 The antigenic domain 1 of the cytomegalovirus glycoprotein B contains an intramolecular disulphide bond J. Gen. Virol 81 2659 2663
12. D Song N Jacques 1997 Cell disruption of Escherichia coli by glass bead stirring for the recovery of recombinant proteins Anal. Biochem 248 300 301
13. K Tsumoto D Ejima I Kumagai T Arakawa 2003 Practical considerations in refolding proteins from inclusion bodies Protein Expr. Purif 28 1 8
14. A Villaverde M Carrió 2003 Protein aggregation in recombinant bacteria: biological role of inclusion bodies Biotechnol. Lett 25 1385 1395